BRIDGEWATER, N.J. — Amneal Pharmaceuticals has been recognized as a top generic drug manufacturer by the Healthcare Distribution Alliance (HDA).
Amneal said that this week it received the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) for Generic Pharmaceutical Product Manufacturer, for the $100 million-plus sales to health care distributors category. HDA presented the DIANA awards at its 2016 Business and Leadership Conference in Colorado Springs, Colo.
Selected by health care distributors, Amneal’s award spotlights pharmaceutical manufacturers who exemplify excellence in business practices with HDA healthcare distributors.
“We are honored to be recognized by our customers for our contributions to enhance the healthcare supply chain,” stated Chirag Patel, co-chief executive officer and chairman of Amneal. “Receiving this recognition is not only an important validation of our collaborative business approach, but it also is a reflection of the commitment and hard work of our employees who work closely with our customers to bring high-quality products to pharmacists, physicians and patients.”
Amneal said that, according to data from IMS Health, it’s now the seventh-largest U.S. generics company by prescriptions and the fastest-growing manufacturer globally, with a diversified portfolio that includes 115 Food and Drug Administration-approved molecules and about 170 in development.